Fellow Eye Outcomes In Subjects With Dry Eye Disease Following Oc-01 (Varenicline Solution) Nasal Spray Treatment: Integrated Data From Onset-1 (Phase 2B) And Onset-2 (Phase 3) Studies

Published 2022 - 40th Congress of the ESCRS

Reference: FPS11.04 | Type: Free paper | DOI: 10.82333/p156-0q23